[Low doses of quetiapine (Seroquel) as an impulsivity corrector in patients with bipolar affective disorder in remission].

Margarita A Morozova Sergei S Potanin Denis S Burminsky Allan G Beniashvili George E Rupchev Taisiya А Lepilkina Mikhail Yu Sorokin Evgeny D Kasyanov Galina N Mazo D A Tarumov A G Trufanov Kirill Markin T Z Beybalaeva A A Katok D S Tsapko

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)

The results of the study showed that add-on of the low doses of quetiapine (Seroquel) significantly decreases impaired impulse control in remitted patients with bipolar affective disorders both in self-evaluation and in risk-taking experimental test. The drop of high level of impulsivity can improve the quality and stability of remission and reduce behavioral risks due to impaired impulse control.

Keyphrases

bipolar disorder
disease activity
obsessive compulsive disorder
ulcerative colitis
borderline personality disorder
systemic lupus erythematosus
climate change